Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study

Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study

Pulmonary arterial hypertension (PAH) is characterized by progressive dyspnea and exercise limitation and is associated with reduced health-related quality of life. Few clinical studies have evaluated the primary effects of treatment of PAH from the patient perspective. Here, we present the impact o...

Full description

Bibliographic Details
Main Authors: Namita Sood, Alvaro Aranda, David Platt, Anneliese LaRose, Frank Kleinjung, Gerald O’Brien
Format: Article
Language:English
Published: Wiley 2019-02-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/2045894018823715

Similar Items

Similar Items